Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Innovent Biologics
Biotech
Innovent’s rival to AbbVie, J&J psoriasis drugs clears phase 2
The anti-IL-23 antibody, which is designed to be given less frequently than some rivals, outperformed placebo in terms of reducing psoriasis.
Nick Paul Taylor
Aug 10, 2022 6:50am
Sanofi pens 'pioneering' cancer drug deal with China's Innovent
Aug 4, 2022 3:07pm
Phase 3 hits tee Innovent up to rival Amgen and Sanofi in PCSK9
Feb 17, 2022 9:40am
Sana inks $204M biobucks pact with IASO, Innovent for CAR access
Jan 11, 2022 3:00pm
Union, Innovent ink $247M biobucks deal for psoriasis therapy
Sep 28, 2021 2:00am
Roche pens $2B biobucks pact with Innovent Biologics
Jun 9, 2020 8:45am
